Status:
COMPLETED
Circular Cyclocoagulation Using HIFU With EYEOP1 Device in Glaucoma Patients
Lead Sponsor:
EyeTechCare
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the effectiveness and the safety of the cyclocoagulation using HIFU in glaucoma patients
Eligibility Criteria
Inclusion
- Primary Open-angle glaucoma included pseudo-exfoliative glaucoma and pigmentary glaucoma
- IOP \> 21 mm Hg on glaucoma medications, and indicated for filtering glaucoma surgery
- Patient must be aged 18 years and more
- No previous cyclophotocoagulation procedure in the eye
- No previous laser treatment in the eye during the 3 months before HIFU procedure
Exclusion
- History of previous glaucoma surgery with implantation of glaucoma drainage device in the study eye
- History of ocular or retrobulbar tumor
- retinal detachment, choroidal hemorrhage or detachment
- Ocular infectious diseasee within 14 days before HIFU procedure
Key Trial Info
Start Date :
November 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01791673
Start Date
November 1 2012
End Date
June 1 2014
Last Update
June 16 2015
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Dijon, France
2
Michallon University Hospital
Grenoble, France
3
Huriez University Hospital
Lille, France
4
Croix Rousse University Hospital
Lyon, France